For a disease to be susceptible to screening, it should be definable, important and treatable. Treatment begun earlier on the basic of discovery through screening must have some advantage. The period between first possible detection and optimal time for treatment must be substantial. Adequate facilities and resources for evaluation and care must be available. Finally, there must be a valid, low-cost test for the disease and there must not be a high cost associated with false-positive or false-negative results.
一种疾病若要适合筛查,应具备可定义性、重要性且可治疗。基于筛查发现而尽早开始的治疗必须具备一定优势。首次可能检测到疾病与最佳治疗时间之间的间隔必须足够长。必须具备用于评估和治疗的充足设施及资源。最后,对于该疾病必须有有效的低成本检测方法,且假阳性或假阴性结果不能带来高昂成本。